Charles Schwab’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Buy |
1,969,875
+47,837
| +2% | +$429K | ﹤0.01% | 1740 |
|
|
2025
Q1 | $14.4M | Sell |
1,922,038
-57,954
| -3% | -$435K | ﹤0.01% | 1789 |
|
|
2024
Q4 | $14.9M | Buy |
1,979,992
+91,998
| +5% | +$692K | ﹤0.01% | 1840 |
|
|
2024
Q3 | $14.3M | Buy |
1,887,994
+102,860
| +6% | +$782K | ﹤0.01% | 1865 |
|
|
2024
Q2 | $11M | Buy |
1,785,134
+53,331
| +3% | +$330K | ﹤0.01% | 1998 |
|
|
2024
Q1 | $8.8M | Buy |
1,731,803
+137,367
| +9% | +$698K | ﹤0.01% | 2048 |
|
|
2023
Q4 | $9.55M | Buy |
1,594,436
+133,629
| +9% | +$800K | ﹤0.01% | 2007 |
|
|
2023
Q3 | $10.3M | Buy |
1,460,807
+19,402
| +1% | +$137K | ﹤0.01% | 1890 |
|
|
2023
Q2 | $10.1M | Buy |
1,441,405
+18,285
| +1% | +$129K | ﹤0.01% | 1903 |
|
|
2023
Q1 | $11.9M | Buy |
1,423,120
+2,733
| +0.2% | +$22.8K | ﹤0.01% | 1789 |
|
|
2022
Q4 | $16.3M | Buy |
1,420,387
+34,239
| +2% | +$393K | 0.01% | 1576 |
|
|
2022
Q3 | $17.5M | Buy |
1,386,148
+29,145
| +2% | +$367K | 0.01% | 1470 |
|
|
2022
Q2 | $14.4M | Buy |
1,357,003
+10,162
| +0.8% | +$108K | 0.01% | 1624 |
|
|
2022
Q1 | $21.9M | Buy |
1,346,841
+72,026
| +6% | +$1.17M | 0.01% | 1474 |
|
|
2021
Q4 | $17.7M | Buy |
1,274,815
+30,649
| +2% | +$425K | 0.01% | 1679 |
|
|
2021
Q3 | $17.9M | Buy |
1,244,166
+17,055
| +1% | +$245K | 0.01% | 1670 |
|
|
2021
Q2 | $19.4M | Buy |
1,227,111
+20,145
| +2% | +$318K | 0.01% | 1610 |
|
|
2021
Q1 | $12.3M | Buy |
1,206,966
+38,275
| +3% | +$389K | ﹤0.01% | 1837 |
|
|
2020
Q4 | $8.71M | Sell |
1,168,691
-1,355
| -0.1% | -$10.1K | ﹤0.01% | 1941 |
|
|
2020
Q3 | $4.02M | Buy |
1,170,046
+242,102
| +26% | +$832K | ﹤0.01% | 2180 |
|
|
2020
Q2 | $4.42M | Buy |
927,944
+68,937
| +8% | +$329K | ﹤0.01% | 2083 |
|
|
2020
Q1 | $1.72M | Buy |
859,007
+23,758
| +3% | +$47.5K | ﹤0.01% | 2324 |
|
|
2019
Q4 | $2.88M | Buy |
835,249
+259,443
| +45% | +$895K | ﹤0.01% | 2297 |
|
|
2019
Q3 | $1.65M | Sell |
575,806
-76,927
| -12% | -$220K | ﹤0.01% | 2446 |
|
|
2019
Q2 | $2.47M | Sell |
652,733
-126,632
| -16% | -$480K | ﹤0.01% | 2299 |
|
|
2019
Q1 | $6.35M | Buy |
779,365
+181,543
| +30% | +$1.48M | ﹤0.01% | 1860 |
|
|
2018
Q4 | $4.83M | Sell |
597,822
-18,081
| -3% | -$146K | ﹤0.01% | 1920 |
|
|
2018
Q3 | $4.7M | Buy |
615,903
+96,843
| +19% | +$739K | ﹤0.01% | 2075 |
|
|
2018
Q2 | $2.98M | Buy |
519,060
+28,084
| +6% | +$161K | ﹤0.01% | 2247 |
|
|
2018
Q1 | $2.34M | Sell |
490,976
-5,816
| -1% | -$27.7K | ﹤0.01% | 2269 |
|
|
2017
Q4 | $2.44M | Buy |
496,792
+176,714
| +55% | +$868K | ﹤0.01% | 2235 |
|
|
2017
Q3 | $1.68M | Buy |
320,078
+12,267
| +4% | +$64.3K | ﹤0.01% | 2347 |
|
|
2017
Q2 | $1.71M | Sell |
307,811
-25,562
| -8% | -$142K | ﹤0.01% | 2270 |
|
|
2017
Q1 | $2.8M | Buy |
333,373
+62,792
| +23% | +$528K | ﹤0.01% | 2058 |
|
|
2016
Q4 | $1.71M | Buy |
270,581
+13,398
| +5% | +$84.8K | ﹤0.01% | 2238 |
|
|
2016
Q3 | $1.14M | Buy |
257,183
+11,454
| +5% | +$50.5K | ﹤0.01% | 2374 |
|
|
2016
Q2 | $698K | Buy |
245,729
+3,528
| +1% | +$10K | ﹤0.01% | 2466 |
|
|
2016
Q1 | $686K | Sell |
242,201
-23,769
| -9% | -$67.3K | ﹤0.01% | 2463 |
|
|
2015
Q4 | $2.75M | Buy |
265,970
+20,210
| +8% | +$209K | ﹤0.01% | 1904 |
|
|
2015
Q3 | $2.8M | Buy |
245,760
+35,885
| +17% | +$409K | ﹤0.01% | 1856 |
|
|
2015
Q2 | $3.13M | Buy |
209,875
+5,769
| +3% | +$86.1K | ﹤0.01% | 1847 |
|
|
2015
Q1 | $1.84M | Sell |
204,106
-274,277
| -57% | -$2.48M | ﹤0.01% | 2094 |
|
|
2014
Q4 | $5.82M | Buy |
478,383
+28,362
| +6% | +$345K | 0.01% | 1333 |
|
|
2014
Q3 | $4.4M | Buy |
450,021
+200,061
| +80% | +$1.96M | 0.01% | 1473 |
|
|
2014
Q2 | $3.19M | Buy |
249,960
+226,060
| +946% | +$2.88M | 0.01% | 1707 |
|
|
2014
Q1 | $253K | Hold |
23,900
| – | – | ﹤0.01% | 2871 |
|
|
2013
Q4 | $182K | Hold |
23,900
| – | – | ﹤0.01% | 2972 |
|
|
2013
Q3 | $182K | Hold |
23,900
| – | – | ﹤0.01% | 2948 |
|
|
2013
Q2 | $39K | Buy |
+23,900
| New | +$39K | ﹤0.01% | 3037 |
|